Batya Swift Yasgur, MA, LSW May 02, 2023 A large proportion of US adults who are prescribed Schedule II stimulants are simultaneously receiving other CNS agents including benzodiazepines, opioids, and antidepressants — a potentially dangerous practice. Investigators analyzed prescription drug claims for over 9.1 million US adults over a 1-year period and found that 276,223 (3%) had used...